Bayesian predictive probability based on a bivariate index vector for single-arm phase II study with binary efficacy and safety endpoints

Takuya Yoshimoto, Satoru Shinoda, Kouji Yamamoto +1

In oncology, phase II studies are crucial for clinical development plans as such studies identify potent agents with sufficient activity to continue development in the subsequent p…